-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: October 2012
“When Genetic Engineering Came Of Age”
October 29 was the 30th anniversary of the approval by the Food and Drug Administration (FDA) of human insulin synthesized in genetically engineered bacteria. In an article for Forbes, Henry Miller, the founding director of the FDA’s Office of Biotechnology, marked the anniversary and commented on today’s regulatory environment: “Regulators have adopted a highly risk-averse and even adversarial mindset, few new drugs are approved without convening extramural advisory committees, and decisions are sometimes hijacked by Read More >
Biotech Patenting Event: BIO’s 2012 Fall IPCC in Charleston, South Carolina
BIO’s 2012 Fall IPCC Conference event on November 12-14 gathers biotech in-house counsels to provide and discuss relevant IP developments. The Honorable Jimmie V. Reyna, Circuit Judge for the United States Court of Appeals for the Federal Circuit keynotes this year’s program along with the Honorable Judge Sally Gardner Lane, Administrative Patent Judge, Trial Division, Board of Patent Appeals and Interferences. Find program topics and speakers below. Click here for the full agenda. Picking the Read More >
It’s World Polio Day – Time to Make History
Oct. 24 is World Polio Day, an opportunity to share a message of extreme importance: The global community must step up now with the resources needed to eradicate this crippling childhood disease once and for all. In all of history, smallpox is the only human disease to be eradicated. It’s time to make global health history a second time by wiping out polio. And that can only happen by reaching every child in every corner Read More >
Pharma & Biotech Companies Donate Hundreds of Millions of Dollars to Copayment Foundations. Here’s Why.
In addition to using their own Patient Assistance Programs, many pharma and biotech companies are supporting independent 501(c)3 non-profit copayment foundations to increase treatment compliance, access to care for insured Americans (including Medicare patients), and to promote proper disease management. Copayment foundations have helped hundreds of thousands of insured Americans afford their coverage and their treatments. The HealthWell Foundation, one of the nation’s largest non-profits, recently issued a white paper on copayment assistance as a Read More >
Biotech is Growing in Colorado
Last month I posted a link to an interview featuring Colorado BioScience Association‘s (CBSA) Executive Vice President, April Giles. The interview briefly touched on some of the innovation happening in the state. Though, I was curious to know a bit more about CBSA’s effort to grow and support the industry. So, I was pleased when April kindly agreed to participate in a Q&A. Her answers below offer insight into critical elements of bioscience economic development Read More >
